<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <meta name="generator" content="pandoc">
  <meta name="author" content="Erin E Gabriel  Michael Daniels and  M Elizabeth Halloran" />
  <meta name="dcterms.date" content="2014-06-17" />
  <title>Comparing Biomarkers as Trial Level General  Surrogates</title>
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no">
  <link rel="stylesheet" href="TLGS_Merck_061014_files/reveal.js-2.6.1/css/reveal.min.css"/>

  <!-- some tweaks to reveal css -->
  <style type="text/css">
    .reveal h1 { font-size: 2.0em; }
    .reveal h2 { font-size: 1.5em;  }
    .reveal h3 { font-size: 1.25em;	}
    .reveal h4 { font-size: 1em;	}

    .reveal .slides>section,
    .reveal .slides>section>section {
      padding: 0px 0px;
    }



    .reveal table {
      border-width: 1px;
      border-spacing: 2px;
      border-style: dotted;
      border-color: gray;
      border-collapse: collapse;
      font-size: 0.7em;
    }

    .reveal table th {
      border-width: 1px;
      padding-left: 10px;
      padding-right: 25px;
      font-weight: bold;
      border-style: dotted;
      border-color: gray;
    }

    .reveal table td {
      border-width: 1px;
      padding-left: 10px;
      padding-right: 25px;
      border-style: dotted;
      border-color: gray;
    }

  </style>

    <style type="text/css">code{white-space: pre;}</style>



<link rel="stylesheet" href="TLGS_Merck_061014_files/reveal.js-2.6.1/css/theme/sky.css" id="theme">


<link rel="stylesheet" media="print" href="TLGS_Merck_061014_files/reveal.js-2.6.1/css/print/pdf.css" />


</head>
<body>

<head>
<style type="text/css">
.reveal .slides p {
text-align: left;
font-family: "Ubuntu", sans-serif;
font-size: 35px;
}
.reveal .slides li {
text-align: left;
font-family: "Ubuntu", sans-serif;
font-size: 35px;
}
.reveal h1 {
text-align: center;
font-family: "Ubuntu", sans-serif;
font-size: 70px;
}
.reveal h2 {
text-align: center;
font-size: 50px;
font-family: "Ubuntu", sans-serif;
text-transform: none;
letter-spacing: normal;
}
.references {
max-height: 630px;
overflow: auto;
}
.reveal blockquote {
background: rgba(255, 166, 32, 0.33);
}
</style>
</head>
  <div class="reveal">
    <div class="slides">

<section>
    <h1 class="title">Comparing Biomarkers as Trial Level General <br> Surrogates</h1>
    <h2 class="author">Erin E Gabriel <br> Michael Daniels and <br> M Elizabeth Halloran</h2>
    <h3 class="date">June 17, 2014</h3>
</section>

<section><section id="background" class="titleslide slide level1"><h1>Background</h1></section><section class="slide level6">

<h2>
Scientific Questions of Interest
</h2>
<p>RotaTeq has different efficacy in different regions: <br></p>
<p>1.) Why does efficacy differ?<br /><br><br />2.) Can we accurately predict what the efficacy will actually be in a new setting?<br /><br><br />3.) Do different biomarkers or combinations of biomarkers at the trial level make better surrogates of RotaTeq efficacy?<br /><br></p>
<p>We are attempting to develop methods to help answer 2&amp;3.<br />This may give us insight into question 1, but we cannot answer this question with our methods.</p>
</section><section class="slide level6">

<h2>
Trial Level General Surrogates
</h2>
<blockquote>
<p>If the trial level treatment effect on a biomarker can be used to accurately predict a trial level clinical treatment effect and this predictive association is generalizable to a setting, then the biomarker is a trial level general surrogate for that clinical outcome in that setting.</p>
</blockquote>
<ul>
<li><p>Gives context-any setting in which accurate prediction is possible</p></li>
<li><p>Defines that it is at the trial level</p></li>
<li><p>Correlation between the (causal) treatment effects; biomarker need not be in the causal pathway</p></li>
<li><p>General clinical trial setting (possible observational trial)</p></li>
</ul>
</section></section>
<section><section id="models-and-estimation" class="titleslide slide level1"><h1>Models and Estimation</h1></section><section class="slide level6">

<h2>
Notation
</h2>
<p><span class="math">\(J\)</span> trials indexed by <span class="math">\(j=\{1 \dots J\}\)</span> have the same clinical endpoint of interest and same candidate GSs</p>
<ul>
<li><span class="math">\(Z_{ij} \in \{0,1\}\)</span> the treatment indicator for subject <span class="math">\(i\)</span> in trial <span class="math">\(j\)</span>, RotaTeq.</li>
<li><span class="math">\(Y_{ij}\)</span> the clinical endpoint, severe diarrhea.</li>
<li><span class="math">\({A}_{ij}\)</span> the candidate trial level GS, antibody level.</li>
</ul>
<p><br></p>
<ul>
<li><span class="math">\(T_{1j}\)</span> the true treatment effect of <span class="math">\(Z\)</span> on the candidate trial level GS.<br /></li>
<li><span class="math">\(T_{2j}\)</span> the true treatment effect of <span class="math">\(Z\)</span> on the clinical outcome Y in trial <span class="math">\(j\)</span></li>
</ul>
</section><section class="slide level6">

<h2>
Relationship of Interest
</h2>
<p>The true treatment effect on the clinical outcome given the true treatment effect on the surrogate outcome.</p>
<p><br> <br></p>
<p><span class="math">\[T_{2j}|T_{1j}\]</span></p>
<p><br></p>
<ul>
<li>We don’t observe either of these values only estimates of them</li>
<li>These values may differ greatly over the set of trials</li>
</ul>
</section><section class="slide level6">

<h2>
Data collection
</h2>

<p>Data can be collected at the subject level over the <span class="math">\(J\)</span> trials<br /><br></p>
<ul>
<li><span class="math">\(\{Z_{ij}, Y_{ij}, {A}_{ij,k}\}\)</span> iid within trial<br /></li>
<li>Independent between trials but not iid<br /><br></li>
</ul>
<p>Data can be collected at the trial level<br /><br></p>
<ul>
<li>estimates of <span class="math">\(T_{1j}\)</span> and <span class="math">\(T_{2j}\)</span><br /></li>
<li>Published and unpublished results<br /></li>
<li>Requires estimates of the standard errors for these estimates</li>
</ul>
</section><section class="slide level6">

<h2>
Within Trial models
</h2>

<p><br> <br></p>
<p><span class="math">\[h_1(E[A_{ij}|Z_{ij}])=\zeta_{0j} + T_{1j} Z_{ij}\]</span></p>
<p><span class="math">\[h_2(E[Y_{ij}|Z_{ij}])=\gamma_{0j} + T_{2j} Z_{ij}\]</span> <br><br /><br></p>
<p>where <span class="math">\(\zeta_{0j}\)</span> and <span class="math">\(\gamma_{0j}\)</span> are the trial specific intercepts</p>
<p>obtain <span class="math">\(\widehat{T}_{1j} \hspace{0.5cm}\hbox{and}\hspace{0.5cm} \widehat{T}_{2j}\)</span></p>
</section><section class="slide level6">

<p><img src="TLGS_Merck_061014_files/figure-revealjs/unnamed-chunk-2.png" title="plot of chunk unnamed-chunk-2" alt="plot of chunk unnamed-chunk-2" style="display: block; margin: auto;" /></p>
</section><section class="slide level6">

<p><img src="TLGS_Merck_061014_files/figure-revealjs/unnamed-chunk-3.png" title="plot of chunk unnamed-chunk-3" alt="plot of chunk unnamed-chunk-3" style="display: block; margin: auto;" /></p>
</section><section class="slide level6">

<p><img src="TLGS_Merck_061014_files/figure-revealjs/unnamed-chunk-4.png" title="plot of chunk unnamed-chunk-4" alt="plot of chunk unnamed-chunk-4" style="display: block; margin: auto;" /></p>
</section><section class="slide level6">

<p><img src="TLGS_Merck_061014_files/figure-revealjs/unnamed-chunk-5.png" title="plot of chunk unnamed-chunk-5" alt="plot of chunk unnamed-chunk-5" style="display: block; margin: auto;" /></p>
</section><section class="slide level6">

<p><img src="TLGS_Merck_061014_files/figure-revealjs/unnamed-chunk-6.png" title="plot of chunk unnamed-chunk-6" alt="plot of chunk unnamed-chunk-6" style="display: block; margin: auto;" /></p>
</section><section class="slide level6">

<h2>
Within Trial Estimation
</h2>
<p>Using an estimating equation approach the joint distribution of the estimated treatment effects can be obtained, <span class="citation" data-cites="Dai12">Dai and Hughes (2012)</span>.<br /><br></p>
<p>As given in <span class="citation" data-cites="Dai12">Dai and Hughes (2012)</span><br />if we obtain the asymptotically linear estimates of <span class="math">\(T_{1j}\)</span> and <span class="math">\(T_{2j}\)</span>, we can estimate the covariance of the estimated values within a trial <span class="math">\(j\)</span>. <br></p>
<ul>
<li>may restrict models that can be assumed for <span class="math">\(h_1\)</span> and <span class="math">\(h_2\)</span>. <br></li>
<li>Full Bayesian Modeling is possible, unlikely to substantially improve evaluation at the trial level, <span class="citation" data-cites="Korn05">Korn, Albert, and McShane (2005)</span>.</li>
</ul>
</section><section class="slide level6">

<h2>
Individual data are not available
</h2>
<p>Our method of candidate trial level GS evaluation and comparison can still be applied to trial level estimates,<br />provided that<br /><br></p>
<ul>
<li><span class="math">\(\widehat{T}_{1j}\)</span> <span class="math">\(\widehat{T}_{2j}\)</span> for the same <span class="math">\({A}\)</span> and <span class="math">\(Y\)</span><br /></li>
<li>Estimation error <span class="math">\(\hat{\sigma}_{1j}, \hat{\sigma}_{2j}\)</span><br /><br></li>
</ul>
</section><section class="slide level6">

<h2>
Between Trial: Likelihood
</h2>
<p>If we observe or use the frequentist within trial estimation procedure to obtain <span class="math">\(\widehat{T}_{1j}\)</span> and <span class="math">\(\widehat{T}_{2j}\)</span>, we assume that these estimates are consistent; such that<br /><span class="math">\[
E[\widehat{T}_{1j}]\rightarrow T_{1j} 
\]</span> <span class="math">\[
E[\widehat{T}_{2j}]\rightarrow T_{2j}.  
\]</span> <br></p>
<p>Trial specific normal likelihoods for the observed estimated treatment effects given the true treatment effects<br /><span class="math">\[f_{1jk}(\widehat{T}_{1j}|T_{1j},\hat{\sigma}_{1j})\]</span><br /><span class="math">\[f_{2j}(\widehat{T}_{2j}|T_{2j}, \hat{\sigma}_{2j})\]</span></p>
</section><section class="slide level6">

<h2>
Between Trial: Working Conditional Independence
</h2>
<p>We can assume that these estimates are conditionally independent, allowing us to derive the joint likelihood within a given trial based on these assumed models, by:<br /><br></p>
<p><span class="math">\[f_{j}(\widehat{T}_{1j},\widehat{T}_{2j}|\hat{\sigma}_{1j,k}, \hat{\sigma}_{2j},T_{2j},T_{1j})\]</span><br /><span class="math">\[=f_{1j}(\widehat{T}_{1j}|T_{1j},\hat{\sigma}_{1j}) \times f_{2j}(\widehat{T}_{2j}|T_{2j},\hat{\sigma}_{2j})\]</span>.<br /><br></p>
<p>The joint likelihood over all the trials is given by <span class="math">\(f=\prod^{J}_{j=1}{f_{j}}\)</span></p>
</section><section class="slide level6">

<h2>
Between Trial: Joint Likelihood
</h2>
<p>As outlined in <span class="citation" data-cites="Dai12">Dai and Hughes (2012)</span>, we do not have to assume conditional independence between the estimates for the trials with available data. We can instead estimate the asymptotic joint distribution of <span class="math">\((\widehat{T}_{1j}, \widehat{T}_{2j})\)</span>: <span class="math">\[
f_{jk}(\widehat{T}_{1j},\widehat{T}_{1j}|\hat{\sigma}_{1j}, \hat{\sigma}_{2j},T_{2j},T_{1j})
\sim\]</span><br /><span class="math">\[N \left\{
\left(\begin{array}{c}
 T_{1j}\\
 T_{j2}
      \end{array} \right)
\left(\begin{array}{cc}
\hat{\sigma}^{2}_{1j}&amp; \hat{\sigma}_{12j} \\
 \hat{\sigma}_{12j}&amp;\hat{\sigma}^{2}_{2j}
      \end{array} \right) \right\}
\]</span>.</p>
<p>This can be used as the likelihood for any trial with the required individual data. <span class="math">\(f_k\)</span> may be the product of any set of the conditional working independence likelihoods and the joint likelihoods.</p>
</section><section class="slide level6">

<h2>
Priors, <span class="math">\(T_{1j}\)</span>
</h2>
<p><br> We assume a Dirichlet process mixture (DPM) of Gaussians for the distribution of the true treatment effect on the candidate trial level GS, <span class="math">\(T_{1j}\)</span>. Given by: <br></p>
<p><span class="math">\[
T_{1j} \sim N(\mu_{1j},\tau_{1j})
\]</span></p>
<p><span class="math">\[
(\mu_{1j},\tau_{1j}|G) \sim G \hspace{2cm} G \sim DP(\alpha, G_0)
\]</span></p>
<p><span class="math">\[
DP(\alpha, G_0) = \sum_{m=1}^{M} \alpha_m q(\mu_{1m}|\theta)*f(\tau_{1m}|\zeta).
\]</span></p>
</section><section class="slide level6">

<h2>
Priors, <span class="math">\(T_{2j}\)</span>
</h2>
<p>Adaptive spline model <span class="math">\(q(t_{2j}|T_{1j},\beta,\nu)\)</span> <br></p>
<p>Allows for a very flexible relationship between the true treatment effects</p>
<ul>
<li><span class="math">\(t_{2j}=m(T_{1j}, \beta) + \epsilon_j\)</span><br /></li>
<li><span class="math">\(m(T_{1j}, \beta_k) = \beta_0 + \beta_1 T_{1j} + \beta_2 T_{1j}^{2}+\)</span><br /></li>
<li><span class="math">\(\sum^{J}_{j=1}{b_j|T_{1j}-k_{j}|^{3}}\)</span></li>
</ul>
<p><span class="math">\(\epsilon_j\)</span> are i.i.d <span class="math">\(N(0,\sigma_{\epsilon})\)</span> and <span class="math">\(b_j \sim N(0, \kappa^{2}_{b})\)</span>.</p>
</section><section class="slide level6">

<h2>
Joint Prior
</h2>
<p>The joint prior of <span class="math">\(T_{2j}\)</span>, <span class="math">\(T_{1j}\)</span> and <span class="math">\(\beta\)</span> and the rest of the parameters and hyper-parameters, which we will denote as <span class="math">\(\nu\)</span>, <span class="math">\(\nu=\{\tau^{2}_{1k},\tau^{2}_{2},\mu_{2},\mu_{1}, \kappa^{2}_{b} ,b_m \ldots\}\)</span>, is given by: <br> <br> <span class="math">\[\pi(T_{2j},T_{1j},\beta,\nu)=\]</span> <span class="math">\[g(T_{1j}|\mu_{1},\tau_{1})*q(t_{2j}|T_{1j},\beta,\nu)*\pi(\beta|\nu)*\pi(\nu).\]</span></p>
</section><section class="slide level6">

<h2>
Full Posterior
</h2>
<p>We can then use the joint likelihood and the joint prior to define the joint posterior of interest.</p>
<p>We will denote this posterior by <span class="math">\(P_k(T_{2j},T_{1j},\beta_k, \nu| O_{J})\)</span> for compactness, where <span class="math">\(O_{J}\)</span> is all observed data in all <span class="math">\(J\)</span> trials.</p>
</section><section class="slide level6">

<h2>
Estimation
</h2>
<p>Estimation can carried out by MCMC using a Gibbs sampling program. <br> <br></p>
<p>Gibbs sampling allows for us to update the full conditional distribution for each parameter, holding the other parameters constant at their last update. <br> <br></p>
<p>We use JAGS for our simulations, but Winbugs and R both have boxed samplers that can be used as well. *The R Gibbs did not seem to mix properly for this model…</p>
</section></section>
<section><section id="prediction" class="titleslide slide level1"><h1>Prediction</h1></section><section class="slide level6">

<h2>
Predictive Posterior
</h2>
<p>Although we do not observe <span class="math">\(\widehat{T}_{2J+1}\)</span> or <span class="math">\(\hat{\sigma}_{2J+1}\)</span>, the likelihood for this information is included in the model. <br></p>
<ul>
<li>The missing data are treated like parameters<br /></li>
<li>Prior defined by the <span class="math">\(f^{*}_{J+1}\)</span> using hyper-parameters,<span class="math">\(\tau^{2}_{1},T_{2J+1},\beta\)</span></li>
<li>Observed data <span class="math">\(\widehat{T}_{1J+1}\)</span> and <span class="math">\(\hat{\sigma}_{1J+1}\)</span>. <br></li>
</ul>
<p>After running the Gibbs sampler for this model, we can sample directly from the marginal posterior of <span class="math">\(T_{2J+1}\)</span> given the data <span class="math">\(P(T_{2J+1}|O_{J},\widehat{T}_{1J+1}, \widehat{\sigma}_{1J+1})\)</span>, which is the desired posterior distribution.</p>
</section></section>
<section><section id="evaluation-and-comparison-of-candidate-trial-level-gs" class="titleslide slide level1"><h1>Evaluation and Comparison of Candidate trial level GS</h1></section><section class="slide level6">

<h2>
Prediction Error
</h2>
<p>Given a new trial setting <br></p>
<ul>
<li>We are interested in estimating the error we might expect to make using our predictive model</li>
<li>The absolute difference between the truth and the predicted value, <span class="math">\(D\)</span>
<ul>
<li>Is on the scale of the clinical outcome</li>
<li>Has asymptotic properties under iid data, <span class="citation" data-cites="Tian07">Tian et al. (2007)</span></li>
</ul></li>
</ul>
</section><section class="slide level6">

<h2>
Absolute prediction Error
</h2> 

<p>Properties of <span class="citation" data-cites="Tian07">Tian et al. (2007)</span> absolute prediction error do not hold</p>
<ul>
<li>We don’t observe the truth even in the evaluation trials and differences</li>
<li>We would not expect the differences to be iid <br></li>
</ul>
<p><span class="math">\[D_{J+1, k} = E|T_{2J+1}- E[T_{2J+1}|\widehat{T}_{1J+1}, \widehat{\sigma}_{1J+1}]|\]</span></p>
</section><section class="slide level6">

<h2>
Estimation <span class="math">\(D_{J+1,k}\)</span>
</h2>
<p><br> To estimate <span class="math">\(D_{J+1, k}\)</span>, we first obtain <span class="math">\(D_{j,k}\)</span> for a given observed trial <span class="math">\(j\)</span>. <br></p>
<ul>
<li>If we obtain estimates for <span class="math">\(D_{j,k}\)</span> for all <span class="math">\(J\)</span> trial we can estimate <span class="math">\(D_{J+1,k}\)</span><br /></li>
<li>Each trial will provide evidence of the predictive ability of the trial level GS in a new setting</li>
<li>The average error made in the <span class="math">\(J\)</span> predictions over the trials gives us our best estimate of the error we are likely to make in a new trial setting outside the evaluation sets</li>
</ul>
</section><section class="slide level6">

<h2>
Estimation <span class="math">\(D_{j,k}\)</span>: <span class="math">\(T_{2j}\)</span>
</h2>

<p><br> <span class="math">\[D_{J+1, k} = E|T_{2J+1}- E[T_{2J+1}|\widehat{T}_{1J+1}, \widehat{\sigma}_{1J+1}]|\]</span> <br></p>
<p>The marginal posterior distribution of <span class="math">\(T_{2j}\)</span> can be calculated using all observed estimates related to the clinical outcome, i.e. <span class="math">\(\{\widehat{T}_{2j}, \widehat{\sigma}_{2j}\}\)</span>, over all the evaluation trials alone; we will denote this as <span class="math">\(O_{2J}\)</span>. <br></p>
<p><span class="math">\[T_{2j}|O_{2J}\]</span> <br></p>
</section><section class="slide level6">

<h2> 
Estimation <span class="math">\(D_{j,k}\)</span>: <span class="math">\(E[T_{2j}|O_{J},\widehat{T}_{ij}, \widehat{\sigma}_{ij}]\)</span>
</h2>
<p><br> <span class="math">\[D_{J+1, k} = E|T_{2J+1}- E[T_{2J+1}|\widehat{T}_{1J+1}, \widehat{\sigma}_{1J+1}]|\]</span> <br></p>
<p>leave-the-<span class="math">\(j\)</span>th-trial-out estimate of <span class="math">\(P(T_{2j}|O_{J(-j)}, \widehat{T}_{1j}, \widehat{\sigma}_{1j,k})\)</span>, where <span class="math">\(O_{J(-j)}\)</span> is all information in all <span class="math">\(\{1 \dots J\}\)</span> less the clinical outcome information in trial <span class="math">\(j\)</span>. <br></p>
<ul>
<li><span class="math">\(E[T_{2j}|O_{J(-j)},\widehat{T}_{1j}, \widehat{\sigma}_{1j}]\)</span>.<br /><br></li>
</ul>
<p>This is the same predictive distribution as given above for <span class="math">\(T_{2J+1}\)</span></p>
</section><section class="slide level6">

<h2>
Estimation <span class="math">\(D_{J+1,k}\)</span>
</h2>
<p><br> <span class="math">\[\widetilde{D}_{j,k}=E[|T_{2j}|O_{2J} - E[T_{2j}|O_{J(-j)},\widehat{T}_{1j}, \widehat{\sigma}_{1j}]|]\]</span><br /><br></p>
<ul>
<li>where the outside expectation is taken with respect to the marginal posterior distribution of <span class="math">\(T_{2j}\)</span>. <br></li>
</ul>
<p><span class="math">\[\widetilde{D}_{J+1,k} \sim \widetilde{D}_{j,k}\]</span></p>
</section><section class="slide level6">

<h2>
Evaluation
</h2>
<p>We considered evaluation two ways: <br> Classical</p>
<ul>
<li>The CI for <span class="math">\(P(T_{2J+1}|O_{J},\widehat{T}_{1J+1},\widehat{\sigma}_{1J+1})\)</span></li>
<li>The model fit for the full marginal posterior</li>
<li>For each trial <span class="math">\(j\)</span>, the CI of <span class="math">\(P(T_{2j}|O_{J},\widehat{T}_{1j}, \widehat{\sigma}_{1j})\)</span> <br></li>
</ul>
<p>Predictive error</p>
<ul>
<li>Expected absolute prediction error-how much error to expect in your prediction</li>
<li>Absolute prediction error <span class="math">\(D_{J+1}\)</span></li>
</ul>
</section><section class="slide level6">

<h2>
Absolute prediction error: Evaluation
</h2>
<p>Evaluation of candidate GS for usefulness will also depend on size of a clinically relevant change in the primary outcome. <br></p>
<ul>
<li>If the <span class="math">\(E[\tilde{D}_{J+1}]\)</span> is relatively small,</li>
<li>If the CI of <span class="math">\(\tilde{D}_{J+1}\)</span> are larger than the smallest clinically relevant change in the clinical outcome,</li>
<li>If formal inference is desired <span class="math">\(\tilde{D}_{J+1}\)</span> can be compared to the null model <span class="math">\(\tilde{D}_{J+1,0}\)</span>.</li>
</ul>
</section><section class="slide level6">

<h2>
Comparison of candidate trial level GS
</h2>
<p>Smaller posterior medians, modes and means of <span class="math">\(\tilde{D}_{J+1}\)</span> with tighter posterior credible intervals (CI) indicate better candidate trial level GS. <br></p>
<ul>
<li>Comparison of the <span class="math">\(\tilde{D}_{J+1,k}\)</span> histograms is very useful.</li>
<li>The posterior probability of <span class="math">\(E[D_{J+1,l}]&gt;E[D_{J+1,k}]\)</span> is of interest for quantifying evidence for the superiority of candidate k,
<ul>
<li>Either of the <span class="math">\(\tilde{D}_{J+1}\)</span> posterior distributions can be used as reference for the other candidate mean value.</li>
<li>When Candidate <span class="math">\(l\)</span> is the null model, this is a test of any general surrogate quality.</li>
</ul></li>
</ul>
</section></section>
<section><section id="generalizibility" class="titleslide slide level1"><h1>Generalizibility</h1></section><section class="slide level6">

<h2>
Generalizibility
</h2>

<p>Information to support generalizibility is based on the characteristics of the new trial. One needs information on the <span class="math">\(J\)</span> evaluation settings and the <span class="math">\(J+1\)</span> new setting:</p>
<ul>
<li>Are the new setting’s characteristics, represented, within the range of, or outside the range of the evaluation settings’ characteristics?</li>
<li>Is observed data adequate?</li>
</ul>
<p>We make suggestions for conveying the information available to support the assumption of generalizability.</p>
</section></section>
<section><section id="conclusions" class="titleslide slide level1"><h1>Conclusions</h1></section><section class="slide level6">

<h2>
Preliminary Results
</h2>
<p>Between-trial estimation simulations suggest <br></p>
<p>that the method: <br></p>
<ul>
<li>Is adequately unbiased.</li>
<li>Shows a noticeable difference between the <span class="math">\(D_{J+1}\)</span> estimates of good and useless trial level candidate GS.</li>
<li>Indicates that the CI of <span class="math">\(D_{J+1}\)</span> increase and decrease as expected with the sampling and true between trial error.</li>
<li>Works for linear multivariate candidates <span class="math">\(T_{2j}|T_{1j,k}, T_{1j,q}\)</span>. <br></li>
</ul>
<p>More testing is needed to: <br></p>
<ul>
<li>For higher order polynomials of <span class="math">\(T_{2j}|T_{1j}\)</span> and <span class="math">\(T_{2j}|T_{1j}, T_{1j,m}\)</span>,</li>
<li>Sensitivity analysis for prior assumptions.</li>
</ul>
</section><section class="slide level6">

<h2>
Summary
</h2>
<p>We Have:</p>
<ul>
<li>Provided a flexible method to predict point and interval estimates for the treatment effect on the clinical endpoint in a new trial <span class="math">\(J+1\)</span><br /></li>
<li>Suggested an easily interpretable summary of the predictive quality outside the evaluation trials, <span class="math">\(D_{J+1}\)</span><br /></li>
<li>Shown how <span class="math">\(D_{J+1}\)</span> can be used to compare and evaluate candidate trial level GS<br /></li>
<li>Outlined a nomenclature for the support of generalization of an evaluated trial level GS to a new setting<br /></li>
<li>Extended our univariate methods to allow for multivariate candidate trial level GS</li>
</ul>
</section><section class="slide level6">

<h2>
Summary
</h2>
<p>We need to:</p>
<ul>
<li>Start simulations for the within-trial estimation setting<br /></li>
<li>Tailor simulations to the RotaTeq data
<ul>
<li><span class="citation" data-cites="Dai12">Dai and Hughes (2012)</span> method</li>
<li>GLM plus working conditional independence assumption for within trial estimation to determine performance differences</li>
</ul></li>
<li>Perform sensitivity analysis to prior assumptions with both types of estimation <br></li>
</ul>
<p>**Analyze RotaTeq data using our method to evaluate and compare candidate trial level GS</p>
</section><section class="slide level6">

<h2>
Acknowledgments
</h2>

<p>I would like to thank my Co-authors</p>
<p>Professor Halloran and Professor Daniels<br /><br></p>
<p>Dr. Michael Sachs for coding help<br /><br></p>
<p>Merck and all RotaTeq for the opportunity to develop these methods in the context of their RotaTeq data.</p>
</section><section class="slide level6">

<h2>
References
</h2>






<div class="references">
<p>Dai, J. Y., and J. P. Hughes. 2012. “A Unified Procedure for Meta-Analytic Evaluation of Surrogate End Points in Randomized Clinical Trials.” <em>Biostatistics</em> 13 (4): 609–24.</p>
<p>Korn, Edward L., Paul S. Albert, and Lisa M. McShane. 2005. “Assessing Surrogates as Trial Endpoints Using Mixed Models.” <em>Statistics in Medicine</em> 24 (2): 163–82.</p>
<p>Tian, Lu, Tianxi Cai, Els Goetghebeur, and L. J. Wei. 2007. “Model Evaluation Based on the Sampling Distribution of Estimated Absolute Prediction Error.” <em>Biometrika</em> 94 (2): 297–311.</p>
</div>
</section></section>
    </div>
  </div>

  <script src="TLGS_Merck_061014_files/reveal.js-2.6.1/lib/js/head.min.js"></script>
  <script src="TLGS_Merck_061014_files/reveal.js-2.6.1/js/reveal.min.js"></script>

  <script>

      // Full list of configuration options available here:
      // https://github.com/hakimel/reveal.js#configuration
      Reveal.initialize({
        controls: true,
        progress: true,
        history: true,
        center: true,
        transition: 'default',

        // Optional libraries used to extend on reveal.js
        dependencies: []});
    </script>

  <!-- dynamically load mathjax for compatibility with --self-contained -->
  <script>
    (function () {
      var script = document.createElement("script");
      script.type = "text/javascript";
      script.src  = "TLGS_Merck_061014_files/mathjax-2.3.0/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
      document.getElementsByTagName("head")[0].appendChild(script);
    })();
  </script>

  </body>
</html>
